MIEYX
Price
$14.40
Change
+$0.16 (+1.12%)
Updated
Dec 24 closing price
VTSMX
Price
$144.64
Change
+$1.55 (+1.08%)
Updated
Dec 24 closing price
Ad is loading...

MIEYX vs VTSMX

Header iconMIEYX vs VTSMX Comparison
Open Charts MIEYX vs VTSMXBanner chart's image
MM S&P 500® Index Adm
Price$14.40
Change+$0.16 (+1.12%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx I
Price$144.64
Change+$1.55 (+1.08%)
VolumeN/A
CapitalizationN/A
MIEYX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MIEYX vs. VTSMX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIEYX is a StrongBuy and VTSMX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.84T vs. MIEYX (2.37B). VTSMX pays higher dividends than MIEYX: VTSMX (1.26) vs MIEYX (0.97). MIEYX was incepted earlier than VTSMX: MIEYX (27 years) vs VTSMX (33 years). MIEYX (2.00) and VTSMX (2.00) have comparable annual turnover. MIEYX has a lower initial minimum investment than VTSMX: MIEYX (0) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 25.71 vs. MIEYX (-1.95). VTSMX return over 5 years is better than : 81.67 vs. MIEYX (-15.73).
MIEYXVTSMXMIEYX / VTSMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years33 years-
Gain YTD-2.28325.355-9%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.37B1.84T0%
Annual Yield % from dividends0.971.2677%
Returns for 1 year-1.9525.71-8%
Returns for 3 years-26.9924.27-111%
Returns for 5 years-15.7381.67-19%
Returns for 10 years-10.81186.91-6%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK10.660.40
+3.90%
CleanSpark
GLW47.900.40
+0.84%
Corning
STEL28.770.11
+0.38%
Stellar Bancorp
MG8.77-0.12
-1.35%
Mistras Group
SABS4.10-0.18
-4.21%
SAB Biotherapeutics